Evaluation of the Expression Pattern of rAAV2/1, 2/5, 2/7, 2/8, and 2/9 Serotypes With Different Promoters in the Mouse Visual Cortex

被引:36
|
作者
Scheyltjens, Isabelle [1 ]
Laramee, Marie-Eve [1 ]
Van den Haute, Chris [2 ,3 ]
Gijsbers, Rik [3 ,4 ]
Debyser, Zeger [4 ]
Baekelandt, Veerle [2 ]
Vreysen, Samme [1 ]
Arckens, Lutgarde [1 ]
机构
[1] Katholieke Univ Leuven, Lab Neuroplast & Neuroprote, Dept Biol, B-3000 Leuven, Belgium
[2] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Dept Neurosci, B-3000 Leuven, Belgium
[3] Katholieke Univ Leuven, Leuven Viral Vector Core, B-3000 Leuven, Belgium
[4] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, B-3000 Leuven, Belgium
关键词
viral vector; GABA; CMV; CaMKII alpha; connectivity; optogenetic; ADENOASSOCIATED VIRUS TYPE-2; NONHUMAN PRIMATE BRAIN; CENTRAL-NERVOUS-SYSTEM; VIRAL VECTORS; GENE-THERAPY; ARCHITECTONIC PARCELLATION; NEUROFILAMENT PROTEIN; TRANSGENE EXPRESSION; NIGROSTRIATAL SYSTEM; CORTICAL-NEURONS;
D O I
10.1002/cne.23819
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study compared the expression pattern, laminar distribution, and cell specificity of several rAAV serotypes (2/1, 2/5, 2/7, 2/8, and 2/9) injected in the primary visual cortex (V1) of adult C57Bl/6J mice. In order to obtain specific expression in certain neuron subtypes, different promoter sequences were evaluated for excitatory cell specificity: a universal cytomegalovirus (CMV) promoter, and two versions of the excitatory neuron-specific Ca2+/calmodulin-dependent kinase subunit alpha (CaMKII alpha) promoter, CaMKII alpha 0.4 and CaMKII alpha 1.3. The spatial distribution as well as the cell type specificity was immunohistochemically verified. Depending on the rAAV serotype used, the transduced volume expressing reporter protein differed substantially (rAAV2/5 >> 2/7 approximate to 2/9 approximate to 2/8 >> 2/1). Excitatory neuron-specific targeting was promoter dependent, with a surprising difference between the 1.3 kb and 0.4 kb CaMKII alpha promoters. While CaMKII alpha 1.3 and CMV carrying vectors were comparable, with 78% of the transduced neurons being excitatory for CMV and 82% for CaMKII alpha 1.3, the shorter CaMKII alpha 0.4 version resulted in 95% excitatory specificity. This study therefore puts forward the CaMKII alpha 0.4 promoter as the best choice to target excitatory neurons with rAAVs. Together, these results can be used as an aid to select the most optimal vector system to deliver transgenes into specific rodent neocortical circuits, allowing further elucidation of their functions. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:2019 / 2042
页数:24
相关论文
共 50 条
  • [31] Retina transduction by rAAV2 after intravitreal injection: comparison between mouse and rat
    Dias, Mariana S.
    Araujo, Victor G.
    Vasconcelos, Taliane
    Li, Qiuhong
    Hauswirth, William W.
    Linden, Rafael
    Petrs-Silva, Hilda
    GENE THERAPY, 2019, 26 (12) : 479 - 490
  • [32] Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain
    Taymans, Jean-Marc
    Vandenberghe, Luk H.
    Van Den Haute, Chris
    Thiry, Irina
    Deroose, Christophe M.
    Mortelmans, Luc
    Wilson, James M.
    Debyser, Zeger
    Baekelandt, Veerle
    HUMAN GENE THERAPY, 2007, 18 (03) : 195 - 206
  • [33] The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5
    M S Weinberg
    B L Blake
    R J Samulski
    T J McCown
    Gene Therapy, 2011, 18 : 961 - 968
  • [34] The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5
    Weinberg, M. S.
    Blake, B. L.
    Samulski, R. J.
    McCown, T. J.
    GENE THERAPY, 2011, 18 (10) : 961 - 968
  • [35] Efficient Gene Transfer Into the Mouse Lung by Fetal Intratracheal Injection of rAAV2/6.2
    Carlon, Marianne
    Toelen, Jaan
    Van der Perren, Anke
    Vandenberghe, Luk H.
    Reumers, Veerle
    Sbragia, Lourenco
    Gijsbers, Rik
    Baekelandt, Veerle
    Himmelreich, Uwe
    Wilson, James M.
    Deprest, Jan
    Debyser, Zeger
    MOLECULAR THERAPY, 2010, 18 (12) : 2130 - 2138
  • [36] rAAV2/9 Mediated Gene Delivery of Acid α-Glucosidase Corrects the Cardiac Phenotype in a Mouse Model of Pompe Disease
    Pacak, Christina A.
    Mah, Cathryn
    Cresawn, Kerry O.
    Lewis, Melissa A.
    Germain, Sean
    Byrne, Barry J.
    MOLECULAR THERAPY, 2006, 13 : S12 - S12
  • [37] Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
    Aschauer, Dominik F.
    Kreuz, Sebastian
    Rumpel, Simon
    PLOS ONE, 2013, 8 (09):
  • [38] Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques
    Fischer, AC
    Beck, SE
    Smith, CI
    Laube, BL
    Askin, FB
    Guggino, SE
    Adams, RJ
    Flotte, TR
    Guggino, WB
    MOLECULAR THERAPY, 2003, 8 (06) : 918 - 926
  • [39] Stability Evaluation of rAAV Serotype 1, 2, 8,9 and Wild-Type AAV2 Under Various Conditions
    Tomono, Taro
    Hirai, Yukihiko
    Chono, Hideto
    Huang, Shuohao
    Kawano, Yasuhiro
    Mineno, Junichi
    Ishii, Akiko
    Tamaoka, Akira
    Onodera, Masafumi
    Okada, Takashi
    MOLECULAR THERAPY, 2019, 27 (04) : 101 - 101
  • [40] Different expression pattern of Foxp1 and Foxp2 in the mouse cerebral cortex during postnatal development
    Hisaoka, Tomoko
    Morikawa, Yoshihiro
    Senba, Emiko
    NEUROSCIENCE RESEARCH, 2010, 68 : E362 - E362